The impact of frailty on outcomes for organ transplant recipients is gaining widespread attention in transplant programs around the world. In numerous studies, frailty has been associated with increased length of stay, increased hospitalizations, increased costs, and increased mortality.
Baylor Scott & White The Heart Hospital – Plano is playing a key role in developing a first-of-its-kind wound imaging device equipped with artificial intelligence to noninvasively evaluate wounds and chronically ischemic limbs. The WISCR (Wound Imaging System to Collect Clinical References) study is collecting wound images and data to further develop the DeepView Wound Imaging System device.
At the Vascular & Diabetic Foot Center at Baylor Scott & White The Heart Hospital – Plano, the focus is both to treat foot and ankle wounds and to prevent those wounds from occurring in the first place. As the only coordinated outpatient and inpatient program in North Texas with comprehensive care for the diabetic and vascular conditions affecting the foot, the Center takes a holistic approach to care.
With CT-derived fractional flow reserve (FFRct) analysis, Baylor Scott & White The Heart Hospital – Plano provides insight into the impact blockages have on blood flow in the heart – all without a trip to the cath lab. Especially for intermediate blockages, this advanced, noninvasive technology offers cardiologists critical information to determine if a blockage is not significant.
Baylor Scott & White The Heart Hospital – Plano is the only site in Dallas-Fort Worth currently enrolling participants in the SOLVE CRT trial. This innovative trial is evaluating a new cardiac resynchronization therapy (CRT) system that delivers pacing stimulation from inside the left ventricle – possibly eliminating the need for traditional left ventricular lead placement.
